Dx Dialogues: Indolent Systemic Mastocytosis

In these videos, hematologist and medical oncologist Dr. Sanjay Juneja discusses the often vague presenting symptoms of indolent systemic mastocytosis (ISM) and the importance of maintaining a high clinical suspicion for diagnosis. Dr. Juneja also covers emerging therapies, including recent pharmacologic advancements for targeting the KIT mutation found in most patients with ISM and ongoing research into the use of monoclonal antibodies to treat ISM.